Position in MRK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$80,857,340
+$3,659,309 QoQ
Shares Held
629,240
-2.0% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#236
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Boston Partners holds $3,635,506,449 across 12 Drug Manufacturers - General names. MRK ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,784,316 | $1,203,925,277 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
6,017,958 | $760,308,811 | |
| 3 | AZN |
Astrazeneca PLC
|
3,177,627 | $602,541,630 | |
| 4 | JNJ |
Johnson & Johnson
|
1,113,805 | $282,873,054 | |
| 5 | BIIB |
Biogen Inc.
|
1,263,429 | $272,976,467 | |
| 6 | AMGN |
Amgen Inc
|
637,923 | $231,004,675 | |
| 7 | SNY |
Sanofi
|
3,844,844 | $164,021,044 | |
| 8 | MRK |
Merck & Co., Inc.
This page
|
629,240 | $80,857,340 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,857,340 | 629,240 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $77,198,031 | 641,766 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $70,389,676 | 668,722 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $58,992,884 | 702,882 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $60,477,685 | 763,993 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $69,396,596 | 773,135 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $77,275,365 | 776,793 | Shares | Other | 2025-02-11 | |
| 2024-09-30 | $137,766,449 | 1,213,160 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $151,171,065 | 1,221,091 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $166,333,529 | 1,260,580 | Shares | Defined | 2024-05-28 | |
| 2023-12-31 | $141,209,680 | 1,295,264 | Shares | Other | 2024-02-07 | |
| 2023-09-30 | $143,228,157 | 1,391,240 | Shares | Other | 2023-11-08 | |
| 2023-06-30 | $166,643,582 | 1,444,177 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $167,799,690 | 1,577,213 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $179,018,156 | 1,613,503 | Shares | Other | 2023-02-08 | |
| 2022-09-30 | $147,669,532 | 1,714,695 | Shares | Other | 2022-11-09 | |
| 2022-06-30 | $165,623,523 | 1,816,645 | Shares | Other | 2022-08-10 | |
| 2022-03-31 | $154,703,879 | 1,885,483 | Shares | Other | 2022-05-10 | |
| 2021-12-31 | $148,894,658 | 1,942,780 | Shares | Other | 2022-02-04 | |
| 2021-09-30 | $209,521,746 | 2,789,532 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $205,125,137 | 2,637,587 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $191,339,254 | 2,482,023 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $143,286,457 | 1,751,669 | Shares | Other | 2021-02-10 | |
| 2020-09-30 | $398,955,424 | 4,809,587 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $410,220,979 | 5,304,808 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $494,966,429 | 6,433,151 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||